These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the fiscal year ended December 31, 2010 | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the Transition Period from to |
|
New York
(State or Other Jurisdiction of Incorporation or organization) |
16-0961359
(IRS Employer Identification No.) |
|
|
2200 Rand Building, Buffalo, NY
(Address of Principal executive offices) |
14203
(Zip Code) |
|
Title of Each Class
|
Name of Exchange on Which Registered
|
|
| Common Stock, $0.10 par value | NASDAQ Capital Market |
| Large accelerated filer o | Accelerated filer o | Non-accelerated filer þ | Smaller reporting company o |
| Item 1. | Business |
1
2
| | Rand and Rand SBIC to engage in certain related party transactions that the Corporation would otherwise be permitted to engage in as a BDC if its component parts were organized as a single corporation; | |
| | Rand, as a BDC, and Rand SBIC, as its BDC/SBIC subsidiary, to meet asset coverage requirements for senior securities on a consolidated basis; and | |
| | Rand SBIC, as a BDC/SBIC subsidiary of Rand as a BDC, to file Exchange Act reports on a consolidated basis as part of Rands Exchange Act reports. |
3
| Item 1A. | Risk Factors |
4
5
| Item 1B. | Unresolved Staff Comments |
| Item 2. | Properties |
| Item 3. | Legal Proceedings |
| Item 4. | Removed and Reserved |
6
| Item 5. | Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
|
2010 Quarter ending:
|
High | Low | ||||||
|
March 31st
|
$ | 3.84 | $ | 3.20 | ||||
|
June 30th
|
$ | 3.77 | $ | 3.00 | ||||
|
September 30th
|
$ | 3.39 | $ | 2.70 | ||||
|
December 31st
|
$ | 3.80 | $ | 2.97 | ||||
|
2009 Quarter ending:
|
High | Low | ||||||
|
March 31st
|
$ | 4.00 | $ | 3.19 | ||||
|
June 30th
|
$ | 4.15 | $ | 2.97 | ||||
|
September 30th
|
$ | 3.95 | $ | 3.15 | ||||
|
December 31st
|
$ | 4.05 | $ | 3.54 | ||||
7
8
| COMPANY/INDEX/MARKET | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | ||||||||||||||||||||||||
|
Rand Capital Corporation
|
$ | 100.00 | $ | 261.19 | $ | 268.51 | $ | 261.19 | $ | 297.01 | $ | 241.04 | ||||||||||||||||||
|
NASDAQ Market Index
|
$ | 100.00 | $ | 110.25 | $ | 121.88 | $ | 73.10 | $ | 106.22 | $ | 125.36 | ||||||||||||||||||
|
Peer Group Index
|
$ | 100.00 | $ | 132.25 | $ | 94.96 | $ | 38.19 | $ | 67.87 | $ | 97.90 | ||||||||||||||||||
9
| Item 6. | Selected Financial Data |
| 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|
Total assets
|
$ | 35,091,260 | $ | 35,631,371 | $ | 32,228,797 | $ | 32,722,151 | $ | 29,463,944 | ||||||||||
|
Total liabilities
|
$ | 12,040,442 | $ | 12,425,490 | $ | 12,001,831 | $ | 12,904,328 | $ | 12,681,539 | ||||||||||
|
Net assets
|
$ | 23,050,818 | $ | 23,205,881 | $ | 20,226,966 | $ | 19,817,823 | $ | 16,782,405 | ||||||||||
|
Net asset value per outstanding share
|
$ | 3.38 | $ | 3.40 | $ | 3.54 | $ | 3.47 | $ | 2.93 | ||||||||||
|
Common stock shares outstanding
|
6,818,934 | 6,818,934 | 5,718,934 | 5,718,934 | 5,718,934 | |||||||||||||||
| 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|
Investment income
|
$ | 847,283 | $ | 1,749,525 | $ | 1,757,003 | $ | 2,302,870 | $ | 1,326,962 | ||||||||||
|
Total expenses
|
$ | 2,367,911 | $ | 1,850,113 | $ | 1,721,555 | $ | 1,650,947 | $ | 1,519,184 | ||||||||||
|
Net investment (loss) gain
|
$ | (973,189 | ) | $ | (63,878 | ) | $ | 135,689 | $ | 398,703 | $ | (1,264,802 | ) | |||||||
|
Net realized gain (loss) on sales and dispositions of
investments, net of tax
|
$ | 3,222,688 | $ | 2,007,974 | | $ | (42,045 | ) | $ | 3,456,441 | ||||||||||
|
Net (decrease) increase in unrealized appreciation, net of tax
|
$ | (2,404,562 | ) | $ | (2,683,516 | ) | $ | 273,454 | $ | 2,362,507 | $ | 5,974,832 | ||||||||
|
Net (decrease) increase in net assets from operations
|
$ | (155,063 | ) | $ | (739,420 | ) | $ | 409,143 | $ | 2,719,165 | $ | 8,166,471 | ||||||||
10
| Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
11
12
| | Loan and debt securities are generally valued at the price the security would command in order to provide a yield to maturity equivalent to the current yield of similar debt securities. A debt instrument may be reduced in value if it is judged to be of poor quality and collection is in doubt. A debt security may also be valued based on the estimated proceeds from the sale of a portfolio company at its estimated fair value. | |
| | Equity securities may be valued using the market approach or income approach. The market approach uses observable prices and other relevant information generated by similar market transactions. It may include the use of market multiples derived from a set of comparables to assist in pricing the investment. Additionally, the Corporation adjusts valuations if a subsequent significant equity financing has occurred that includes a meaningful portion of the financing by a sophisticated, unrelated new investor. The income approach employs a cash flow and discounting methodology to value an investment. |
13
14
| 12/31/10 | 12/31/09 | (Decrease) | % (Decrease) | |||||||||||||
|
Total assets
|
$ | 35,091,260 | $ | 35,631,371 | $ | (540,111 | ) | (1.5 | )% | |||||||
|
Total liabilities
|
12,040,442 | 12,425,490 | (385,048 | ) | (3.1 | )% | ||||||||||
|
Net assets
|
$ | 23,050,818 | $ | 23,205,881 | $ | (155,063 | ) | (0.7 | )% | |||||||
| 12/31/10 | 12/31/09 | (Decrease) | % (Decrease) | |||||||||||||
|
Investments, at cost
|
$ | 13,573,041 | $ | 14,767,920 | $ | (1,194,879 | ) | (8.1 | )% | |||||||
|
Unrealized appreciation, net
|
5,791,584 | 9,528,225 | (3,736,641 | ) | (39.2 | )% | ||||||||||
|
Investments, at fair value
|
$ | 19,364,625 | $ | 24,296,145 | $ | (4,931,520 | ) | (20.3 | )% | |||||||
15
|
New Investments:
|
Amount | |||
|
Microcision LLC (Microcision)
|
$ | 850,000 | ||
|
Mid America Brick (Mid America)
|
800,000 | |||
|
Liazon Corporation (Liazon)
|
501,200 | |||
|
Rheonix, Inc. (Rheonix)
|
500,000 | |||
|
GridApp Systems, Inc. (GridApp)
|
480,000 | |||
|
Chequed.com, Inc. (Chequed)
|
250,000 | |||
|
Niagara Dispensing Technologies, Inc. (Niagara Dispensing)
|
225,000 | |||
|
Total of investments made during the year ended
December 31, 2010
|
3,606,200 | |||
|
Changes to Investments:
|
||||
|
EmergingMed.com, Inc (Emerging Med) interest conversion
|
216,712 | |||
|
Microcision interest conversion
|
73,472 | |||
|
Niagara Dispensing interest conversion
|
36,918 | |||
|
Mezmeriz, Inc (Mezmeriz) interest conversion
|
21,509 | |||
|
SOMS Technologies, LLC (SOMS) interest conversion
|
15,897 | |||
|
GridApp interest conversion
|
1,774 | |||
|
Total changes to investments during the year ended
December 31, 2010
|
366,282 | |||
|
Investments Repaid, Sold or Liquidated:
|
||||
|
GripApp
|
(1,577,708 | ) | ||
|
Innov-X Systems Inc (Innovex)
|
(1,250,000 | ) | ||
|
Wineisit.com Corporation (Wineisit)
|
(721,918 | ) | ||
|
Golden Goal LLC (Golden Goal)
|
(675,652 | ) | ||
|
APF Group, Inc. (APF)
|
(631,547 | ) | ||
|
Gemcor II, LLC (Gemcor)
|
(110,286 | ) | ||
|
Photonic Products Group, Inc. (Photonics)
|
(76,250 | ) | ||
|
Adam
|
(68,000 | ) | ||
|
Bioworks, Inc. (Bioworks)
|
(56,000 | ) | ||
|
Total of investments repaid, sold or liquidated during the
year ended December 31, 2010
|
(5,167,361 | ) | ||
|
Total change in investments, at cost, during the year ended
December 31, 2010
|
$ | (1,194,879 | ) | |
|
Fair Value at
|
% of Total Assets
|
|||||||||
|
December 31,
|
at December 31,
|
|||||||||
|
Company
|
Industry | 2010 | 2010 | |||||||
|
Gemcor
|
Manufacturing Aerospace
Machinery |
$ | 6,113,596 | 17 | % | |||||
|
Synacor Inc. (Synacor)
|
Software | $ | 4,168,001 | 12 | % | |||||
|
Microcision
|
Manufacturing Medical Products | $ | 1,582,282 | 5 | % | |||||
|
Carolina Skiff LLC (Carolina Skiff)
|
Manufacturing Boats | $ | 1,500,000 | 4 | % | |||||
|
Ultra-Scan Corporation (Ultra-Scan)
|
Electronics Hardware/Software | $ | 1,203,000 | 3 | % | |||||
16
|
Fair Value at
|
% of Total Assets
|
|||||||||
|
December 31,
|
at December 31,
|
|||||||||
|
Company
|
Industry | 2009 | 2009 | |||||||
|
Innovex
|
Manufacturing Metals Testing Equipment | $ | 6,300,000 | 18 | % | |||||
|
Gemcor
|
Manufacturing Aerospace Machinery | $ | 6,223,883 | 17 | % | |||||
|
Synacor
|
Software | $ | 4,168,001 | 12 | % | |||||
|
Carolina Skiff
|
Manufacturing Boats | $ | 1,500,000 | 4 | % | |||||
|
Ultra-Scan
|
Electronics Hardware/Software | $ | 1,203,000 | 3 | % | |||||
|
% of Net Asset Value at
|
% of Net Asset Value at
|
|||||||
|
Geographic Region
|
December 31, 2010 | December 31, 2009 | ||||||
|
USA East
|
92 | % | 94 | % | ||||
|
USA South
|
8 | % | 6 | % | ||||
| 100 | % | 100 | % | |||||
|
Percentage of
|
Percentage of
|
|||||||||||||||
| Cost | Total Portfolio | Fair Value | Total Portfolio | |||||||||||||
|
December 31, 2010:
|
||||||||||||||||
|
Subordinated Debt and Promissory Notes
|
$ | 3,792,655 | 28 | % | $ | 3,345,326 | 17 | % | ||||||||
|
Convertible Debt
|
663,596 | 5 | 663,596 | 4 | ||||||||||||
|
Equity and Partnership Interests
|
9,078,590 | 67 | 15,317,503 | 79 | ||||||||||||
|
Equity Warrants
|
38,200 | | 38,200 | 0 | ||||||||||||
|
Total
|
$ | 13,573,041 | 100 | % | $ | 19,364,625 | 100 | % | ||||||||
|
December 31, 2009:
|
||||||||||||||||
|
Subordinated Debt and Promissory Notes
|
$ | 3,320,606 | 23 | % | $ | 1,617,141 | 7 | % | ||||||||
|
Convertible Debt
|
2,661,847 | 18 | 2,347,674 | 10 | ||||||||||||
|
Equity and Partnership Interests
|
8,717,467 | 59 | 15,213,330 | 62 | ||||||||||||
|
Equity Warrants
|
68,000 | | 5,118,000 | 21 | ||||||||||||
|
Total
|
$ | 14,767,920 | 100 | % | $ | 24,296,145 | 100 | % | ||||||||
17
|
December 31,
|
December 31,
|
Increase
|
% Increase
|
|||||||||||||
| 2010 | 2009 | (Decrease) | (Decrease) | |||||||||||||
|
Interest from portfolio companies
|
$ | 688,177 | $ | 568,524 | $ | 119,653 | 21.0 | % | ||||||||
|
Interest from other investments
|
23,574 | 17,129 | 6,445 | 37.6 | % | |||||||||||
|
Dividend and other investment income
|
120,071 | 1,133,102 | (1,013,031 | ) | (89.4 | )% | ||||||||||
|
Other income
|
15,461 | 30,770 | (15,309 | ) | (49.8 | )% | ||||||||||
|
Total investment income
|
$ | 847,283 | $ | 1,749,525 | $ | (902,242 | ) | (51.6 | )% | |||||||
|
Interest
|
Investment
|
Year that Interest
|
||||||||||
|
Company
|
Rate | Cost | Accrual Ceased | |||||||||
|
Associates Interactive LLC (Associates)
|
8 | % | $ | 291,331 | 2009 | |||||||
|
G-Tec Natural Gas Systems (G-Tec)
|
8 | % | $ | 400,000 | 2004 | |||||||
|
Niagara Dispensing
|
14 | % | $ | 547,328 | 2010 | |||||||
18
|
December 31,
|
December 31,
|
(Decrease)
|
% (Decrease)
|
|||||||||||||
| 2009 | 2008 | Increase | Increase | |||||||||||||
|
Interest from portfolio companies
|
$ | 568,524 | $ | 608,180 | $ | (39,656 | ) | (6.5 | )% | |||||||
|
Interest from other investments
|
17,129 | 90,660 | (73,531 | ) | (81.1 | )% | ||||||||||
|
Dividend and other investment income
|
1,133,102 | 1,027,377 | 105,725 | 10.3 | % | |||||||||||
|
Other income
|
30,770 | 30,786 | (16 | ) | (0.1 | )% | ||||||||||
|
Total investment income
|
$ | 1,749,525 | $ | 1,757,003 | $ | (7,478 | ) | (0.4 | )% | |||||||
|
Interest
|
Investment
|
Year that Interest
|
||||||||||
|
Company
|
Rate | Cost | Accrual Ceased | |||||||||
|
APF
|
8 | % | $ | 631,547 | 2009 | |||||||
|
Associates Interactive LLC (Associates)
|
8 | % | $ | 293,518 | 2009 | |||||||
|
Golden Goal LLC
|
13 | % | $ | 675,652 | 2009 | |||||||
|
G-Tec Natural Gas Systems (G-Tec)
|
8 | % | $ | 400,000 | 2004 | |||||||
|
UStec, Inc. (Ustec)
|
5 | % | 100,000 | 2006 | ||||||||
|
WineIsIt.com (Wineisit)
|
10 | % | 801,918 | 2005 | ||||||||
|
December 31,
|
December 31,
|
|||||||||||||||
| 2010 | 2009 | Increase | % Increase | |||||||||||||
|
Total expenses
|
$ | 2,367,911 | $ | 1,850,113 | $ | 517,798 | 28.0 | % | ||||||||
19
|
December 31,
|
December 31,
|
|||||||||||||||
| 2009 | 2008 | Increase | % Increase | |||||||||||||
|
Total expenses
|
$ | 1,850,113 | $ | 1,721,555 | $ | 128,558 | 7.5 | % | ||||||||
|
December 31,
|
December 31,
|
|||||||||||||||
| 2010 | 2009 | Change | % Increase | |||||||||||||
|
Realized gain
|
$ | 4,962,742 | $ | 3,161,913 | $ | 1,800,829 | 57.0 | % | ||||||||
20
|
December 31,
|
December 31,
|
|||||||||||
| 2009 | 2008 | Change | ||||||||||
|
Realized Gain
|
$ | 3,161,913 | | $ | 3,161,913 | |||||||
|
December 31,
|
December 31,
|
|||||||||||
| 2010 | 2009 | Change | ||||||||||
|
Change in Unrealized Appreciation
|
$ | (3,736,642 | ) | $ | (4,211,605 | ) | $ | 474,963 | ||||
21
|
Valuation
|
||||
|
Change
|
||||
|
Portfolio Company
|
during 2010 | |||
|
Reclass Wineisit to a realized loss
|
721,918 | |||
|
Reclass Golden Goal to a realized loss
|
656,652 | |||
|
Reclass APF to a realized loss
|
631,547 | |||
|
Reclass GridApp to realized gain
|
295,935 | |||
|
Advantage 24/7
|
100,000 | |||
|
Reclass Bioworks, Inc. to a realized loss
|
56,000 | |||
|
SOMS appreciation
|
55,717 | |||
|
Reclass Photonics to a realized loss
|
45,752 | |||
|
Niagara Dispensing depreciation
|
(1,250,163 | ) | ||
|
Reclass Innovex to realized gain
|
(5,050,000 | ) | ||
|
Total Change in Unrealized Appreciation during the year ended
December 31, 2010
|
$ | (3,736,642 | ) | |
|
December 31,
|
December 31,
|
|||||||||||||||
| 2009 | 2008 | Decrease | % Decrease | |||||||||||||
|
Change in Unrealized Appreciation
|
$ | (4,211,605 | ) | $ | 601,985 | $ | (4,813,590 | ) | (800 | %) | ||||||
|
Valuation
|
||||
|
Change
|
||||
|
Portfolio Company
|
during 2009 | |||
|
Reclass Rocket Broadband to a realized loss
|
$ | 715,000 | ||
|
Rheonix Inc. (Rheonix)
|
136,000 | |||
|
Photonics
|
7,250 | |||
|
Adam
|
(65,341 | ) | ||
|
G-Tec Natural Gas Systems (Gtec)
|
(98,000 | ) | ||
|
Associates Interactive, LLC (Associates)
|
(293,518 | ) | ||
|
GridApp
|
(295,935 | ) | ||
|
APF
|
(324,213 | ) | ||
|
Niagara Dispensing
|
(367,951 | ) | ||
|
Golden Goal
|
(419,238 | ) | ||
|
Reclass Kionix, Inc. (Kionix) to realized gain
|
(493,959 | ) | ||
|
Innovex
|
(2,711,700 | ) | ||
|
Total Change in Unrealized Appreciation during the year ended
December 31, 2009
|
$ | (4,211,605 | ) | |
22
23
| Cash Receipts due by year | ||||||||||||||||||||
|
2015 and
|
||||||||||||||||||||
| 2011 | 2012 | 2013 | 2014 | beyond | ||||||||||||||||
|
Scheduled Cash Receipts from Portfolio Companies
|
$ | 290,000 | $ | 2,823,000 | $ | 2,974,000 | $ | 213,000 | $ | 1,602,000 | ||||||||||
24
| Payments due by period | ||||||||||||||||||||
|
Less than
|
1-3
|
3-5
|
More
|
|||||||||||||||||
| Total | 1 year | years | years | than 5 yrs | ||||||||||||||||
|
SBA Debentures
|
$ | 10,000,000 | $ | 0 | $ | 0 | $ | 5,400,000 | $ | 4,600,000 | ||||||||||
|
Operating Lease Obligations (Rent of office space)
|
$ | 87,600 | $ | 16,800 | $ | 34,680 | $ | 36,120 | $ | 0 | ||||||||||
|
Total
|
$ | 10,087,600 | $ | 16,800 | $ | 34,680 | $ | 5,436,120 | $ | 4,600,000 | ||||||||||
| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk |
25
| Item 8. | Financial Statements and Supplementary Data |
| 27 | ||||
| 28 | ||||
| 29 | ||||
| 30 | ||||
| 31 | ||||
| 34 | ||||
| 35 | ||||
| 47 | ||||
| 48 |
26
| 2010 | 2009 | |||||||
|
Assets
|
||||||||
|
Investments at fair value (identified cost: 2010
$13,573,041, 2009 $14,767,920)
|
$ | 19,364,625 | $ | 24,296,145 | ||||
|
Cash and cash equivalents
|
11,698,653 | 9,417,236 | ||||||
|
Interest receivable (net of allowance 2010 $158,245,
2009 $209,089)
|
1,051,848 | 1,192,118 | ||||||
|
Prepaid income taxes
|
414,745 | | ||||||
|
Other assets
|
2,561,389 | 725,872 | ||||||
|
Total assets
|
$ | 35,091,260 | $ | 35,631,371 | ||||
| Liabilities and Stockholders Equity (net assets) | ||||||||
|
Liabilities:
|
||||||||
|
Debentures guaranteed by the SBA
|
$ | 10,000,000 | $ | 9,100,000 | ||||
|
Deferred tax liability
|
1,044,315 | 1,809,000 | ||||||
|
Income taxes payable
|
| 1,082,646 | ||||||
|
Accounts payable and accrued expenses
|
990,477 | 431,233 | ||||||
|
Deferred revenue
|
5,650 | 2,611 | ||||||
|
Total liabilities
|
12,040,442 | 12,425,490 | ||||||
|
Stockholders equity (net assets):
|
||||||||
|
Common stock, $.10 par; shares authorized 10,000,000;
shares issued 6,863,034
|
686,304 | 686,304 | ||||||
|
Capital in excess of par value
|
10,581,789 | 10,581,789 | ||||||
|
Accumulated net investment (loss)
|
(7,674,968 | ) | (4,961,725 | ) | ||||
|
Undistributed net realized gain on investments
|
15,860,132 | 10,897,390 | ||||||
|
Net unrealized appreciation on investments
|
3,644,767 | 6,049,329 | ||||||
|
Treasury stock, at cost, 44,100 shares
|
(47,206 | ) | (47,206 | ) | ||||
|
Net assets (per share 2010 $3.38, 2009
$3.40)
|
23,050,818 | 23,205,881 | ||||||
|
Total liabilities and stockholders equity (net
assets)
|
$ | 35,091,260 | $ | 35,631,371 | ||||
27
| 2010 | 2009 | 2008 | ||||||||||
|
Investment income:
|
||||||||||||
|
Interest from portfolio companies
|
$ | 688,177 | $ | 568,524 | $ | 608,180 | ||||||
|
Interest from other investments
|
23,574 | 17,129 | 90,660 | |||||||||
|
Dividend and other investment income
|
120,071 | 1,133,102 | 1,027,377 | |||||||||
|
Other income
|
15,461 | 30,770 | 30,786 | |||||||||
| 847,283 | 1,749,525 | 1,757,003 | ||||||||||
|
Operating expenses:
|
||||||||||||
|
Salaries
|
1,120,834 | 623,765 | 440,337 | |||||||||
|
Employee benefits
|
190,336 | 126,046 | 121,659 | |||||||||
|
Directors fees
|
88,500 | 76,750 | 77,250 | |||||||||
|
Professional fees
|
161,862 | 227,415 | 248,667 | |||||||||
|
Stockholders and office operating
|
122,029 | 140,554 | 120,260 | |||||||||
|
Insurance
|
39,133 | 49,988 | 41,489 | |||||||||
|
Corporate development
|
60,849 | 55,749 | 65,042 | |||||||||
|
Other operating
|
15,636 | (34,718 | ) | 83,972 | ||||||||
| 1,799,179 | 1,265,549 | 1,198,676 | ||||||||||
|
Interest on SBA obligations
|
574,715 | 497,475 | 522,062 | |||||||||
|
Bad debt (recovery) expense
|
(5,983 | ) | 87,089 | 817 | ||||||||
|
Total expenses
|
2,367,911 | 1,850,113 | 1,721,555 | |||||||||
|
Investment (loss) gain before income taxes
|
(1,520,628 | ) | (100,588 | ) | 35,448 | |||||||
|
Income tax benefit
|
(547,439 | ) | (36,710 | ) | (100,241 | ) | ||||||
|
Net investment (loss) gain
|
(973,189 | ) | (63,878 | ) | 135,689 | |||||||
|
Realized and unrealized gain (loss) on investments:
|
||||||||||||
|
Realized gain on sales and dispositions, net
|
4,962,742 | 3,161,913 | | |||||||||
|
Income tax expense
|
1,740,054 | 1,153,939 | | |||||||||
|
Net realized gain on investments
|
3,222,688 | 2,007,974 | | |||||||||
|
Unrealized appreciation on investments:
|
||||||||||||
|
Beginning of year
|
9,528,226 | 13,739,831 | 13,137,846 | |||||||||
|
End of year
|
5,791,584 | 9,528,226 | 13,739,831 | |||||||||
|
Change in unrealized appreciation before income taxes
|
(3,736,642 | ) | (4,211,605 | ) | 601,985 | |||||||
|
Deferred income tax (benefit) expense
|
(1,332,080 | ) | (1,528,089 | ) | 328,531 | |||||||
|
Net (decrease) increase in unrealized appreciation
|
(2,404,562 | ) | (2,683,516 | ) | 273,454 | |||||||
|
Net realized and unrealized gain (loss) on investments
|
818,126 | (675,542 | ) | 273,454 | ||||||||
|
Net (decrease) increase in net assets from operations
|
$ | (155,063 | ) | $ | (739,420 | ) | $ | 409,143 | ||||
|
Weighted average shares outstanding
|
6,818,934 | 6,115,081 | 5,718,934 | |||||||||
|
Basic and diluted net (decrease) increase in net assets from
operations per share
|
$ | (0.02 | ) | $ | (0.12 | ) | $ | 0.07 | ||||
28
| 2010 | 2009 | 2008 | ||||||||||
|
Net assets at beginning of period
|
$ | 23,205,881 | $ | 20,226,966 | $ | 19,817,823 | ||||||
|
Net investment (loss) gain
|
(973,189 | ) | (63,878 | ) | 135,689 | |||||||
|
Net realized gain on sales and dispositions of investments
|
3,222,688 | 2,007,974 | | |||||||||
|
Net (decrease) increase in unrealized appreciation
|
(2,404,562 | ) | (2,683,516 | ) | 273,454 | |||||||
|
Net (decrease) increase in net assets from operations
|
(155,063 | ) | (739,420 | ) | 409,143 | |||||||
|
Issuance of common stock
|
| 3,718,335 | | |||||||||
|
Subtotal
|
| 3,718,335 | | |||||||||
|
Net assets at end of period
|
$ | 23,050,818 | $ | 23,205,881 | $ | 20,226,966 | ||||||
29
| 2010 | 2009 | 2008 | ||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net (decrease) increase in net assets from operations
|
$ | (155,063 | ) | $ | (739,420 | ) | $ | 409,143 | ||||
|
Adjustments to reconcile net increase in net assets to net cash
used in operating activities:
|
||||||||||||
|
Depreciation and amortization
|
39,521 | 36,218 | 52,230 | |||||||||
|
Change in interest receivable allowance
|
(50,844 | ) | 86,272 | 817 | ||||||||
|
Decrease (increase) in unrealized appreciation of investments
|
3,736,642 | 4,211,605 | (601,985 | ) | ||||||||
|
Deferred tax benefit
|
(764,685 | ) | (1,681,000 | ) | (465,000 | ) | ||||||
|
Realized gain on portfolio investments, net
|
(4,962,742 | ) | (3,161,913 | ) | | |||||||
|
Payment in kind, interest accrued
|
| (115,334 | ) | (15,380 | ) | |||||||
|
Non-cash conversion of debenture interest
|
(366,282 | ) | (41,599 | ) | (67,235 | ) | ||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Decrease (increase) in interest receivable
|
191,114 | (264,502 | ) | (367,704 | ) | |||||||
|
(Increase) decrease in other assets
|
(63,384 | ) | 137,059 | 779,083 | ||||||||
|
(Increase) in prepaid income taxes
|
(414,745 | ) | | | ||||||||
|
(Decrease) increase in income taxes payable
|
(1,082,646 | ) | 983,923 | (375,742 | ) | |||||||
|
Increase (decrease) in accounts payable and accrued liabilities
|
559,244 | 138,502 | (28,479 | ) | ||||||||
|
Increase (decrease) increase in deferred revenue
|
3,039 | (17,766 | ) | (33,276 | ) | |||||||
|
Total adjustments
|
(3,175,768 | ) | 311,465 | (1,122,671 | ) | |||||||
|
Net cash used in operating activities
|
(3,330,831 | ) | (427,955 | ) | (713,528 | ) | ||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Investments originated
|
(3,606,200 | ) | (2,955,309 | ) | (1,626,657 | ) | ||||||
|
Proceeds from sale of portfolio investments
|
8,230,833 | 4,946,781 | | |||||||||
|
Proceeds from loan repayments
|
110,286 | 420,981 | 713,465 | |||||||||
|
Capital expenditures
|
(846 | ) | | (12,222 | ) | |||||||
|
Net cash provided by (used in) investing activities
|
4,734,073 | 2,412,453 | (925,414 | ) | ||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Issuance of common stock, net
|
| 3,718,335 | | |||||||||
|
Proceeds from SBA debenture
|
900,000 | 1,000,000 | | |||||||||
|
Origination costs to SBA
|
(21,825 | ) | (43,250 | ) | | |||||||
|
Net cash provided by financing activities
|
878,175 | 4,675,085 | | |||||||||
|
Net increase (decrease) in cash and cash equivalents
|
2,281,417 | 6,659,583 | (1,638,942 | ) | ||||||||
|
Cash and cash equivalents:
|
||||||||||||
|
Beginning of year
|
9,417,236 | 2,757,653 | 4,396,595 | |||||||||
|
End of year
|
$ | 11,698,653 | $ | 9,417,236 | $ | 2,757,653 | ||||||
30
|
(b)
|
Per
|
|||||||||||||||||||||
|
Company, Geographic Location, Business
|
Date
|
(c)
|
(d)(f)
|
Share
|
||||||||||||||||||
|
Description, (Industry) and Website
|
Type of Investment | Acquired | Equity | Cost | Value | of Rand | ||||||||||||||||
| Non-Control/Non-Affiliate Investments:(j) | ||||||||||||||||||||||
|
Chequed.com, Inc.(g)
Saratoga Springs, NY. Predictive employee selection and development software. (Software) www.chequed.com |
$250,000 convertible promissory note at 8% due December 31, 2012. | 11/17/10 | 0 | % | $ | 250,000 | $ | 250,000 | $ | .04 | ||||||||||||
|
Liazon Corporation(e)(g)
Buffalo, NY. Employee benefits solution company. (Health Benefits Provider) www.liazon.com |
$500,000 secured promissory note at 8% due November 9, 2015. 120,000 Series C-1 preferred stock. | 11/9/10 | 1 | % | 501,200 | 501,200 | .07 | |||||||||||||||
|
Mezmeriz, Inc.(g)
Ithaca, NY. Developer of micro mirror technology that replaces silicon with carbon fibers in micro-electronic mechanical systems (MEMS) enabling efficient, wide-angle, Pico projectors to be embedded in mobile devices. (Electronics Developer) www.mezmeriz.com |
141,125 Series A preferred shares. | 1/9/08 | 4 | % | 121,509 | 121,509 | .02 | |||||||||||||||
|
Rheonix, Inc.
Ithaca, NY. Developer of microfluidic testing devices including channels, pumps, reaction vessels, & diagnostic chambers, for testing of small volumes of chemicals and biological fluids. (Manufacturing) www.rheonix.com |
9,676 common shares. (g) 694,015 Series A preferred shares. 50,593 common shares. | 10/29/09 | 4 | % | 753,000 | 889,000 | .12 | |||||||||||||||
|
Somerset Gas Transmission Company, LLC(e)
Columbus, OH. Natural gas transportation company. (Oil and Gas) www.somersetgas.com |
26.5337 units. | 7/10/02 | 3 | % | 719,097 | 786,748 | .12 | |||||||||||||||
|
Synacor Inc.(g)
Buffalo, NY. Develops provisioning platforms for aggregation and delivery of content and services across multiple digital devices. (Software) www.synacor.com |
234,558 Series A preferred shares. 600,000 Series B preferred shares. 240,378 Series C preferred shares. 897,438 common shares. | 11/18/02 | 4 | % | 1,349,479 | 4,168,001 | .61 | |||||||||||||||
| Subtotal Non-Control/Non-Affiliate Investments | $ | 3,694,285 | $ | 6,716,458 | $ | .98 | ||||||||||||||||
| Affiliate Investments:(k) | ||||||||||||||||||||||
|
Carolina Skiff LLC(e)(g)
Waycross, GA. Manufacturer of fresh water, ocean fishing and pleasure boats. (Manufacturing) www.carolinaskiff.com |
$985,000 Class A preferred membership interest at 14%. Redeemable December 23, 2012. $500,000 subordinated promissory note at 14% due December 31, 2016. 6.0825% class A common membership interest. (i) Interest receivable $1,019,426. | 1/30/04 | 7 | % | $ | 1,500,000 | $ | 1,500,000 | $ | .22 | ||||||||||||
|
EmergingMed.com, Inc.(e)(g)
New York, NY. Cancer clinical trial matching and referral service. (Software) www.emergingmed.com |
$675,045 senior subordinated note at 8% due January 19, 2013. Warrants for 8% of common stock. | 12/19/05 | 8 | % | 675,045 | 675,045 | .10 | |||||||||||||||
|
Microcision LLC(e)(g)
Philadelphia, PA. Custom manufacturer of medical and dental implants. (Manufacturing). www.microcision.com |
$1,500,000 subordinated promissory note at 5%, 6% deferred interest due December 31, 2013. 15% class A common membership interest. | 9/24/09 | 15 | % | 1,582,282 | 1,582,282 | .23 | |||||||||||||||
31
|
(b)
|
Per
|
|||||||||||||||||||||
|
Company, Geographic Location, Business
|
Date
|
(c)
|
(d)(f)
|
Share
|
||||||||||||||||||
|
Description, (Industry) and Website
|
Type of Investment | Acquired | Equity | Cost | Value | of Rand | ||||||||||||||||
|
Mid America Brick & Structural Clay Products,
LLC(g)
Mexico, MO. Manufacturer of face brick for residential and commercial construction. (Manufacturing). www.midamericabrick.com |
19.524 membership units. | 6/1/10 | 19 | % | 800,000 | 800,000 | .12 | |||||||||||||||
|
Niagara Dispensing Technologies, Inc.
Amherst, NY. Beverage dispensing technology development and products manufacturer, specializing in rapid pour beer dispensing systems for high volume stadium and concession operations. (Manufacturing) www.niagaradispensing.com |
202,081 Series B preferred stock. $25,000 senior secured note at 8% due January 31, 2011. (g) 463,691 Series A preferred stock. 518,752 Series B preferred stock. $300,000 promissory note at 6%, 8% deferred interest due July 30, 2011. $200,000 secured convertible note at 14% due February 19, 2012. Warrants for 190,561 class A common stock. Warrants for 110,672 Series B preferred stock. | 3/8/06 | 14 | % | 1,854,113 | 125,000 | .02 | |||||||||||||||
|
SOMS Technologies, LLC(g)
Valhalla, NY. Produces and markets the microGreen Extended Performance Oil Filter. (Auto Parts Developer) www.microgreenfilter.com |
4,808,224 Series B membership units. | 12/2/08 | 12 | % | 370,687 | 426,403 | .06 | |||||||||||||||
|
Ultra Scan Corporation
Amherst, NY. Biometrics application developer of ultrasonic fingerprint technology. (Electronics Hardware/Software) www.ultra-scan.com |
536,596 common shares. 107,104 Series A-1 preferred shares. (g) 95,284 Series A-1 preferred shares. | 12/11/92 | 2 | % | 938,164 | 1,203,000 | .18 | |||||||||||||||
| Subtotal Affiliate Investments | $ | 7,720,291 | $ | 6,311,730 | $ | .93 | ||||||||||||||||
| Control Investments(l) | ||||||||||||||||||||||
|
Advantage 24/7 LLC(g)
Williamsville, NY. Marketing program for wine and spirits dealers. (Marketing Company) |
50% Membership interest. | 12/30/10 | 50 | % | $ | 100,000 | $ | 100,000 | $ | .02 | ||||||||||||
|
Gemcor II, LLC(e)(g)(h)
West Seneca, NY. Designs and sells automatic riveting machines used in the assembly of aircraft components. (Manufacturing) www.gemcor.com |
$500,000 subordinated promissory note at 15% due December 1, 2014. 25 membership units. Warrant to purchase 6.25 membership units. | 6/28/04 | 31 | % | 913,596 | 6,113,596 | .90 | |||||||||||||||
|
G-TEC Natural Gas Systems
Buffalo, NY. Manufactures and distributes systems that allow natural gas to be used as an alternative fuel to gases. (Manufacturing) www.gas-tec.com |
21.6% Class A membership interest. 8% cumulative dividend. | 8/31/99 | 22 | % | 400,000 | 100,000 | .01 | |||||||||||||||
| Subtotal Control Investments | $ | 1,413,596 | $ | 6,313,596 | $ | .93 | ||||||||||||||||
| Other Investments(a) | Various | $ | 744,869 | $ | 22,841 | $ | 0 | |||||||||||||||
| Total portfolio investments | $ | 13,573,041 | $ | 19,364,625 | $ | 2.84 | ||||||||||||||||
32
| a) | Unrestricted securities are freely marketable securities having readily available market quotations. All other securities are restricted securities, which are subject to one or more restrictions on resale and are not freely marketable. At December 31, 2010 restricted securities represented 100% of the value of the investment portfolio. Freed Maxick & Battaglia, CPAs PC has not examined the business descriptions of the portfolio companies. Individual securities with values less than <$100,000 are included in Other Investments. | |
| (b) | The Date Acquired column indicates the year in which the Corporation acquired its first investment in the company or a predecessor company. Freed Maxick & Battaglia, CPAs, PC has not audited the date acquired of the portfolio companies. | |
| (c) | The equity percentages estimate the Corporations ownership interest in the portfolio investment. The estimated ownership is calculated based on the percent of outstanding voting securities held by the Corporation or the potential percentage of voting securities held by the Corporation upon exercise of warrants or conversion of debentures, or other available data. Freed Maxick & Battaglia, CPAs, PC has not audited the equity percentages of the portfolio companies. The symbol <1% indicates that the Corporation holds an equity interest of less than one percent. | |
| (d) | The Corporation uses Accounting Standards Codification (ASC) 820 Fair Value Measurements which defines fair value and establishes guidelines for measuring fair value. At December 31, 2010, ASC 820 designated all of the Corporations investments as Level 3 assets due to their privately held restricted nature. Under the valuation policy of the Corporation, unrestricted securities are valued at the closing price for publicly held securities for the last three days of the month. Restricted securities, including securities of publicly-held companies, are subject to restrictions on resale, and are valued at fair value as determined by the management of the Corporation and submitted to the Board of Directors for approval. Fair value is considered to be the amount which the Corporation may reasonably expect to receive for portfolio securities when sold on the valuation date. Valuations as of any particular date, however, are not necessarily indicative of amounts which may ultimately be realized as a result of future sales or other dispositions of securities and these favorable or unfavorable differences could be material. Among the factors considered in determining the fair value of restricted securities are the financial condition and operating results, projected operations, and other analytical data relating to the investment. Also considered are the market prices for unrestricted securities of the same class (if applicable) and other matters which may have an impact on the value of the portfolio company. | |
| (e) | These investments are income producing. All other investments are non-income producing. Income producing investments have generated cash payments of interest or dividends within the last twelve months. | |
| (f) | As of December 31, 2010, the total cost of investment securities approximated $13.6 million. Net unrealized appreciation was approximately $5.8 million, which was comprised of $8.5 million of unrealized appreciation of investment securities and $2.7 million related to unrealized depreciation of investment securities. | |
| (g) | Rand Capital SBIC, Inc. investment. | |
| (h) | Reduction in cost and value from previously reported balances reflects current principal repayment. | |
| (i) | Represents interest due (amounts over $50,000 net of reserves) from investment included as interest receivable on the Corporations Balance Sheet. | |
| (j) | Non-Control/Non-Affiliate investments are investments that are neither Control Investments nor Affiliated Investments. | |
| (k) | Affiliate investments are defined by the Investment Company Act of 1940, as amended (1940 Act), as those Non-Control investments in companies in which between 5% and 25% of the voting securities are owned or Rand holds a Board seat. | |
| (l) | Control investments are defined by the 1940 Act as investments in companies in which more than 25% of the voting securities are owned or where greater than 50% of the board representation is maintained. |
33
| Year Ended December 31, | ||||||||||||||||||||
| 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|
Income from investment operations(1):
|
||||||||||||||||||||
|
Investment income
|
$ | 0.12 | $ | 0.28 | $ | 0.31 | $ | 0.40 | $ | 0.23 | ||||||||||
|
Expenses
|
0.34 | 0.30 | 0.30 | 0.29 | 0.26 | |||||||||||||||
|
Investment (loss) gain before income taxes
|
(0.22 | ) | (0.02 | ) | 0.01 | 0.11 | (0.03 | ) | ||||||||||||
|
Income tax (benefit) expense
|
(0.08 | ) | (0.01 | ) | (0.01 | ) | 0.04 | 0.19 | ||||||||||||
|
Net investment (loss)gain
|
(0.14 | ) | (0.01 | ) | 0.02 | 0.07 | (0.22 | ) | ||||||||||||
|
Issuance of common stock
|
0.00 | 0.61 | 0.00 | 0.00 | 0.00 | |||||||||||||||
|
Cumulative effect adjustments for uncertain tax
positions ASC 740
|
0.00 | 0.00 | 0.00 | 0.06 | 0.00 | |||||||||||||||
|
Net realized and unrealized (loss) gain on investments
|
0.12 | (0.11 | ) | 0.05 | 0.41 | 1.65 | ||||||||||||||
|
Increase (decrease) in net asset value
|
(0.02 | ) | 0.49 | 0.07 | 0.54 | 1.43 | ||||||||||||||
|
Net asset value, beginning of year based on weighted average
shares
|
3.40 | 3.54 | 3.47 | 2.93 | 1.51 | |||||||||||||||
|
Net asset value, end of year based on weighted average shares
|
$ | 3.38 | $ | 4.03 | $ | 3.54 | $ | 3.47 | $ | 2.93 | ||||||||||
|
Per share market value, end of year
|
$ | 3.23 | $ | 3.98 | $ | 3.50 | $ | 3.60 | $ | 3.50 | ||||||||||
|
Total return based on market value
|
(18.84 | )% | 13.71 | % | (2.78 | )% | 2.86 | % | 161.2 | % | ||||||||||
|
Total return based on net asset value
|
(0.67 | )% | (3.74 | )% | 2.1 | % | 18.1 | % | 94.8 | % | ||||||||||
|
Supplemental data:
|
||||||||||||||||||||
|
Ratio of expenses before income taxes to average net assets
|
10.24 | % | 8.52 | % | 8.60 | % | 9.02 | % | 11.96 | % | ||||||||||
|
Ratio of expenses including taxes to average net assets
|
7.87 | % | 8.35 | % | 9.10 | % | 10.41 | % | 20.41 | % | ||||||||||
|
Ratio of net investment (loss) gain to average net assets
|
(4.21 | )% | (0.29 | )% | 0.68 | % | 2.18 | % | (9.96 | )% | ||||||||||
|
Portfolio turnover
|
16.5 | % | 11.3 | % | 6.0 | % | 8.6 | % | 18.1 | % | ||||||||||
|
Net assets end of year
|
$ | 23,050,818 | $ | 23,205,881 | $ | 20,226,966 | $ | 19,817,823 | $ | 16,782,405 | ||||||||||
|
Weighted average shares outstanding at end of year
|
6,818,934 | 6,115,081 | 5,718,934 | 5,718,934 | 5,718,934 | |||||||||||||||
| (1) | Per share data are based on weighted average shares outstanding and results are rounded. |
34
| Note 1. | Summary of Significant Accounting Policies |
| | Loan and debt securities are generally valued at the price the security would command in order to provide a yield to maturity equivalent to the current yield of similar debt securities. A debt instrument may be reduced in value if it is judged to be of poor quality and collection is in doubt. A debt security may also be valued based on the estimated proceeds from the sale of a portfolio company at its estimated fair value. | |
| | Equity securities may be valued using the market approach or income approach. The market approach uses observable prices and other relevant information generated by similar market transactions. It may include the use of market multiples derived from a set of comparables to assist in pricing the investment. |
35
| Additionally, the Corporation adjusts valuations if a subsequent significant equity financing has occurred that includes a meaningful portion of the financing by a sophisticated, unrelated new investor. The income approach employs a cash flow and discounting methodology to value an investment. |
36
37
38
| Note 2. | Investments |
| Fair Value Measurements at Reported Date Using | ||||||||||||||||
|
Quoted Prices in
|
Significant Other
|
Significant
|
||||||||||||||
|
Active Markets for
|
Observable
|
Unobservable
|
||||||||||||||
|
December 31,
|
Identical Assets
|
Inputs
|
Inputs
|
|||||||||||||
|
Description
|
2010 | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
|
Loan investments
|
$ | 413,596 | $ | 413,596 | ||||||||||||
|
Debt investments
|
3,595,327 | 3,595,327 | ||||||||||||||
|
Equity investments
|
15,355,702 | 15,355,702 | ||||||||||||||
|
Total Venture Capital Investments
|
$ | 19,364,625 | $ | 0 | $ | 0 | $ | 19,364,625 | ||||||||
| Fair Value Measurements at Reported Date Using | ||||||||||||||||
|
Significant
|
||||||||||||||||
|
Quoted Prices in
|
Other
|
Significant
|
||||||||||||||
|
Active Markets for
|
Observable
|
Unobservable
|
||||||||||||||
|
December 31,
|
Identical Assets
|
Inputs
|
Inputs
|
|||||||||||||
|
Description
|
2009 | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
|
Venture Capital Investments
|
$ | 24,296,145 | $ | 30,498 | $ | 0 | $ | 24,265,647 | ||||||||
|
Fair Value Measurements Using Significant
|
||||||||||||||||
|
Unobservable Inputs (Level 3)
|
||||||||||||||||
| Venture Capital Investments | ||||||||||||||||
|
Loan
|
Debt
|
Equity
|
||||||||||||||
|
Description
|
Investments | Investments | Investments | Total | ||||||||||||
|
Beginning Balance, December 31, 2009, of Level 3
Assets
|
$ | 488,104 | $ | 3,487,120 | $ | 20,290,423 | $ | 24,265,647 | ||||||||
|
Realized Gains or Losses included in net change in net
assets from operations
|
||||||||||||||||
|
Adam
|
(68,000 | ) | (68,000 | ) | ||||||||||||
|
APF Products Group, Inc. (APF)
|
(631,547 | ) | (631,547 | ) | ||||||||||||
|
Bioworks Inc. (Bioworks)
|
(49,830 | ) | (49,830 | ) | ||||||||||||
|
Golden Goal LLC (Golden Goal)
|
(5,560 | ) | (637,414 | ) | (642,974 | ) | ||||||||||
|
GridApp Systems Inc. (GridApp)
|
2,719,569 | 2,719,569 | ||||||||||||||
|
Innov-X Systems Inc (Innovex)
|
4,403,984 | 4,403,984 | ||||||||||||||
|
Wineisit.com, Inc. (Wineisit)
|
(721,918 | ) | (721,918 | ) | ||||||||||||
|
Total Realized Gains and Losses
|
| (1,359,025 | ) | 6,368,309 | 5,009,284 | |||||||||||
|
Unrealized gains or losses included in net change in net
assets from operations
|
||||||||||||||||
|
APF
|
631,547 | 631,547 | ||||||||||||||
|
Bioworks
|
56,000 | 56,000 | ||||||||||||||
|
Golden Goal
|
19,238 | 637,414 | 656,652 | |||||||||||||
|
GridApp
|
295,935 | 295,935 | ||||||||||||||
|
Innovex
|
(5,050,000 | ) | (5,050,000 | ) | ||||||||||||
|
Niagara Dispensing Technologies, Inc. (Niagara Dispensing)
|
(447,327 | ) | (802,835 | ) | (1,250,162 | ) | ||||||||||
|
SOMS Technologies, LLC (SOMS)
|
55,717 | 55,717 | ||||||||||||||
|
Wineisit
|
721,918 | 100,000 | 821,918 | |||||||||||||
|
Total Unrealized Gains and Losses
|
| 925,376 | (4,707,769 | ) | (3,782,393 | ) | ||||||||||
39
|
Fair Value Measurements Using Significant
|
||||||||||||||||
|
Unobservable Inputs (Level 3)
|
||||||||||||||||
| Venture Capital Investments | ||||||||||||||||
|
Loan
|
Debt
|
Equity
|
||||||||||||||
|
Description
|
Investments | Investments | Investments | Total | ||||||||||||
|
Purchases of Securities
|
||||||||||||||||
|
Chequed.com, Inc. (Chequed)
|
250,000 | 250,000 | ||||||||||||||
|
EmergingMed.com, Inc. (Emerging Med)
|
216,712 | 216,712 | ||||||||||||||
|
GridApp
|
481,774 | 481,774 | ||||||||||||||
|
Liazon Corporation (Liazon)
|
463,000 | 38,200 | 501,200 | |||||||||||||
|
Mezmeriz, Inc. (Mezmeriz)
|
21,509 | 21,509 | ||||||||||||||
|
Microcision LLC (Microcision)
|
923,472 | 923,472 | ||||||||||||||
|
Mid America Brick (Mid America)
|
800,000 | 800,000 | ||||||||||||||
|
Niagara Dispensing
|
261,918 | 261,918 | ||||||||||||||
|
Rheonix, Inc. (Rheonix)
|
500,000 | 500,000 | ||||||||||||||
|
SOMS
|
15,897 | 15,897 | ||||||||||||||
|
Total Purchases of Securities
|
| 2,130,999 | 1,841,483 | 3,972,482 | ||||||||||||
|
Repayments of Securities
|
||||||||||||||||
|
Bioworks
|
(6,170 | ) | (6,170 | ) | ||||||||||||
|
Gemcor II, LLC (Gemcor)
|
(74,508 | ) | (35,778 | ) | (110,286 | ) | ||||||||||
|
Golden Goal
|
(32,678 | ) | (32,678 | ) | ||||||||||||
|
GridApp
|
(4,297,277 | ) | (4,297,277 | ) | ||||||||||||
|
Innovex
|
(250,000 | ) | (5,403,984 | ) | (5,653,984 | ) | ||||||||||
|
Total Repayments of Securities
|
(74,508 | ) | (318,456 | ) | (9,707,431 | ) | (10,100,395 | ) | ||||||||
|
Transfers within Level 3
|
(1,270,687 | ) | 1,270,687 | | ||||||||||||
|
Transfers in or out of Level 3
|
| | | | ||||||||||||
|
Ending Balance, December 31, 2010, of Level 3
Assets
|
$ | 413,596 | $ | 3,595,327 | $ | 15,355,702 | $ | 19,364,625 | ||||||||
|
Amount of total gains or losses for the period included in
changes in net assets attributable to the change in unrealized
gains or losses relating to assets still held at the reporting
date and reported within the net realized and unrealized gains
or losses on investments in the Condensed Consolidated Statement
of Operations
|
$ | (3,736,642 | ) | |
|
Amount of realized gains and losses included in changes in net
assets from operations for the period above reported within the
net realized and unrealized gains or losses on investments in
the Condensed Consolidated Statement of Operations
|
4,962,742 | |||
|
Change in unrealized gains or losses relating to assets still
held at reporting date
|
$ | 1,226,100 | ||
40
|
Fair Value Measurements Using Significant
|
||||||||
|
Unobservable Inputs (Level 3)
|
||||||||
| Venture Capital Investments | ||||||||
|
Ending Balance, December 31, 2008, of Level 3
Assets
|
$ | 28,014,282 | ||||||
|
Realized Gains or Losses included in net change in net assets
from operations
|
||||||||
|
Kionix
|
$ | 3,743,245 | ||||||
|
Rocket Broadband
|
$ | (705,030 | ) | |||||
|
Ramsco
|
$ | 155,000 | $ | 3,193,215 | ||||
|
Unrealized gains or losses included in net change in net
assets from operations
|
||||||||
|
Adam
|
$ | (65,341 | ) | |||||
|
APF
|
$ | (324,213 | ) | |||||
|
Associates Interactive
|
$ | (293,518 | ) | |||||
|
Golden Goal
|
$ | (419,238 | ) | |||||
|
GridApp
|
$ | (295,935 | ) | |||||
|
G-Tec
|
$ | (98,000 | ) | |||||
|
Innovex
|
$ | (2,711,700 | ) | |||||
|
Kionix
|
$ | (493,959 | ) | |||||
|
Niagara Dispensing
|
$ | (367,951 | ) | |||||
|
Rheonix
|
$ | 136,000 | ||||||
|
Rocket Broadband realized loss
|
$ | 715,000 | $ | (4,218,855 | ) | |||
|
Purchases of Securities
|
||||||||
|
Associates
|
$ | 43,517 | ||||||
|
APF
|
$ | 24,212 | ||||||
|
Carolina Skiff
|
$ | 500,000 | ||||||
|
Gemcor
|
$ | 500,000 | ||||||
|
Golden Goal
|
$ | 38,238 | ||||||
|
GridApp
|
$ | 429,267 | ||||||
|
Innovex
|
$ | 250,000 | ||||||
|
Microcision
|
$ | 658,808 | ||||||
|
Niagara Dispensing
|
$ | 310,408 | ||||||
|
Rheonix
|
$ | 253,000 | ||||||
|
SOMS
|
$ | 104,790 | $ | 3,112,240 | ||||
|
Repayments of Securities
|
||||||||
|
EmergingMed
|
$ | (41,667 | ) | |||||
|
Gemcor
|
$ | (79,314 | ) | |||||
|
Kionix
|
$ | (5,249,284 | ) | |||||
|
RAMSCO (Ramsco)
|
$ | (455,000 | ) | |||||
|
Rocket Broadband
|
$ | (9,970 | ) | $ | (5,835,235 | ) | ||
|
Transfers in or out of Level 3
|
| |||||||
|
Ending Balance, December 31, 2009, of Level 3
Assets
|
$ | 24,265,647 | ||||||
| The amount of total gains or losses for the period included in changes in net assets attributable to the change in unrealized gains or losses relating to assets still held at the reporting date. | $ | (4,439,896 | ) | |||||
| Gains and losses (realized and unrealized) included in net decrease in net assets from operations for the period above are reported as follows: | ||||||||
|
Net Gain (Loss) on Sales and Dispositions
|
$ | 3,193,215 | ||||||
|
Change in unrealized gains or losses relating to assets still
held at reporting date
|
( $ | 1,246,681 | ) | |||||
41
| Note 3. | Other Assets |
| 2010 | 2009 | |||||||
|
Escrow receivable from GripApp Systems, Inc.
|
$ | 957,563 | | |||||
|
Escrow receivable from Innov-X Systems, Inc.
|
831,420 | | ||||||
|
Escrow receivable from Kionix, Inc.
|
524,926 | $ | 524,926 | |||||
|
Deferred debenture costs
|
174,621 | 187,286 | ||||||
|
Escrow receivable from USTec
|
| 22,199 | ||||||
|
Property, plant and equipment (net)
|
3,609 | 7,794 | ||||||
|
Prepaid expense
|
| 4,374 | ||||||
|
Operating receivables
|
69,250 | 1,492 | ||||||
|
Reserve for uncollectible USTec escrow
|
| (22,199 | ) | |||||
|
Total other assets
|
$ | 2,561,389 | $ | 725,872 | ||||
| Note 4. | Income Taxes |
| 2010 | 2009 | |||||||
|
Operations
|
$ | 975,000 | $ | 1,502,000 | ||||
|
Investments
|
(2,147,000 | ) | (3,479,000 | ) | ||||
|
Tax credit carryforwards
|
128,000 | 168,000 | ||||||
|
Deferred tax liability, net
|
$ | (1,044,000 | ) | $ | (1,809,000 | ) | ||
42
| 2010 | 2009 | 2008 | ||||||||||
|
Current:
|
||||||||||||
|
Federal
|
$ | 588,654 | $ | 1,200,502 | $ | 677,635 | ||||||
|
State
|
36,566 | 69,638 | (5,345 | ) | ||||||||
| 625,220 | 1,270,140 | 672,290 | ||||||||||
|
Deferred:
|
||||||||||||
|
Federal
|
(755,713 | ) | (1,528,770 | ) | (427,692 | ) | ||||||
|
State
|
(8,972 | ) | (152,230 | ) | (16,308 | ) | ||||||
| (764,685 | ) | (1,681,000 | ) | (444,000 | ) | |||||||
|
Total
|
$ | (139,465 | ) | $ | (410,860 | ) | $ | 228,290 | ||||
| 2010 | 2009 | 2008 | ||||||||||
|
Net investment gain and realized gain before income tax expense
|
$ | (294,528 | ) | $ | (1,150,280 | ) | $ | 648,757 | ||||
|
Expected tax expense at statutory rate
|
$ | (100,140 | ) | $ | (391,095 | ) | $ | 241,577 | ||||
|
State net of federal effect
|
18,213 | (54,511 | ) | 15,016 | ||||||||
|
Pass-through benefit from Portfolio Investment
|
(37,214 | ) | (44,052 | ) | (42,500 | ) | ||||||
|
Non-deductible restructuring costs
|
| 43,439 | | |||||||||
|
Realized losses
|
(16,857 | ) | | | ||||||||
|
Other
|
(3,467 | ) | 35,359 | 14,197 | ||||||||
|
Total
|
$ | (139,465 | ) | $ | (410,860 | ) | $ | 228,290 | ||||
|
Balance at December 31, 2007
|
8,500 | |||
|
Increases for positions taken in prior year
|
21,000 | |||
|
Balance at December 31, 2008
|
29,500 | |||
|
Increases for positions taken in prior year
|
66,000 | |||
|
Balance at December 31, 2009
|
$ | 95,500 | ||
|
Decreases for settlements with taxing authorities
|
23,000 | |||
|
Balance at December 31, 2010
|
$ | 72,500 | ||
43
| Note 5. | SBA Debenture Obligations |
|
Maturity Date
|
Leverage | |||
|
2014
|
$ | 3,500,000 | ||
|
2015
|
1,900,000 | |||
|
2016
|
2,700,000 | |||
|
2020
|
1,900,000 | |||
|
Total Outstanding
|
$ | 10,000,000 | ||
| Note 6. | Stockholders Equity (Net Assets) |
44
|
Accumulated
|
Undistributed
|
|||||||||||
|
Net
|
Net Realized
|
Net Unrealized
|
||||||||||
|
Investment
|
Gain
|
on Appreciation
|
||||||||||
| Loss | Investments | on Investments | ||||||||||
|
Balance, December 31, 2008
|
$ | (3,743,908 | ) | $ | 7,735,477 | $ | 8,732,845 | |||||
|
Net increase (decrease) in net assets from operations
|
(1,217,817 | ) | 3,161,913 | (2,683,516 | ) | |||||||
|
Balance, December 31, 2009
|
$ | (4,961,725 | ) | $ | 10,897,390 | $ | 6,049,329 | |||||
|
Net (decrease) increase in net assets from operations
|
(2,713,243 | ) | 4,962,742 | (2,404,562 | ) | |||||||
|
Balance, December 31, 2010
|
$ | (7,674,968 | ) | $ | 15,860,132 | $ | 3,644,767 | |||||
| Note 7. | Stock Option Plans |
| Note 8. | Employee Benefit Plans |
| Note 9. | Commitments and Contingencies |
45
|
|
Quarterly Operations and Earnings Data Unaudited |
|
4th
|
3rd
|
2nd
|
1st
|
|||||||||||||
| Quarter | Quarter | Quarter | Quarter | |||||||||||||
|
2010
|
||||||||||||||||
|
Investment income
|
$ | 233,039 | $ | 227,430 | $ | 198,428 | $ | 188,386 | ||||||||
|
Net increase (decrease) in net assets from operations
|
884,569 | (216,627 | ) | (143,740 | ) | (679,265 | ) | |||||||||
|
Basic and diluted net increase (decrease) in net assets from
operations per share
|
0.13 | (0.03 | ) | (0.02 | ) | (0.10 | ) | |||||||||
|
2009
|
||||||||||||||||
|
Investment income
|
$ | 751,656 | $ | 298,615 | $ | 320,995 | $ | 378,259 | ||||||||
|
Net increase (decrease) in net assets from operations
|
(94,157 | ) | 33,394 | (657,418 | ) | (21,239 | ) | |||||||||
|
Basic and diluted net increase (decrease) in net assets from
operations per share
|
(0.01 | ) | 0.00 | (0.11 | ) | (0.00 | ) | |||||||||
|
|
Allowance for Doubtful Accounts |
| 2010 | 2009 | 2008 | ||||||||||
|
Balance at beginning of year
|
($ | 209,089 | ) | $ | (122,817 | ) | $ | (122,000 | ) | |||
|
Provision for losses
|
| (87,089 | ) | (817 | ) | |||||||
|
Write offs/Recoveries
|
50,844 | 817 | | |||||||||
|
Balance at end of year
|
($ | 158,245 | ) | $ | (209,089 | ) | $ | (122,817 | ) | |||
46
|
Cost
|
||||||||
|
Increase
|
Realized
|
|||||||
| (Decrease) | Gain (Loss) | |||||||
|
New and additions to previous investments
|
||||||||
|
Microcision LLC
|
$ | 923,472 | ||||||
|
Mid America Brick & Structural Clay Products, LLC
|
800,000 | |||||||
|
Liazon Corporation
|
501,200 | |||||||
|
Rheonix, Inc
|
500,000 | |||||||
|
GridApp Systems, Inc.
|
481,774 | |||||||
|
Niagara Dispensing Technologies, Inc.
|
261,918 | |||||||
|
Chequed.com, Inc.
|
250,000 | |||||||
|
EmergingMed.com, Inc.
|
216,712 | |||||||
|
Mezmeriz, Inc.
|
21,509 | |||||||
|
SOMS Technologies, LLC
|
15,897 | |||||||
| 3,972,482 | ||||||||
|
Investments repaid, sold or liquidated
|
||||||||
|
GridApp repayment
|
(1,577,708 | ) | $ | 2,719,569 | ||||
|
Innov-X Systems, Inc. repayment
|
(1,250,000 | ) | 4,403,984 | |||||
|
Wineisit.com realized loss
|
(721,918 | ) | (721,918 | ) | ||||
|
Golden Goal, LLC realized loss
|
(675,652 | ) | (642,974 | ) | ||||
|
APF Group, Inc. realized loss
|
(631,547 | ) | (631,547 | ) | ||||
|
Gemcor LLC repayment
|
(110,286 | ) | | |||||
|
Photonic Products Group, Inc. sale
|
(76,250 | ) | (46,542 | ) | ||||
|
Adam realized loss
|
(68,000 | ) | (68,000 | ) | ||||
|
Bioworks, Inc. sale
|
(56,000 | ) | (49,830 | ) | ||||
| (5,167,361 | ) | $ | 4,962,742 | |||||
|
Net change in investments
|
$ | (1,194,879 | ) | $ | 4,962,742 | |||
47
48
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
| Item 9A. | Controls and Procedures |
| Item 9B. | Other Information |
| Item 10. | Directors, Executive Officers, and Corporate Governance |
49
| Item 11. | Executive Compensation |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
| Item 13. | Certain Relationships and Related Transactions and Director Independence |
| Item 14. | Principal Accountant Fees and Services |
| Item 15. | Exhibits, Financial Statement Schedules |
50
| (b) | The following exhibits are filed with this report or are incorporated herein by reference to a prior filing, in accordance with Rule 12b-32 under the Securities Exchange Act of 1934. |
| (3)(i) | Certificate of Incorporation of the Corporation, incorporated by reference to Exhibit (a)(1) of Form N-2 filed with the Securities Exchange Commission on April 22, 1997. |
| (3)(ii) | By-laws of the Corporation incorporated by reference to Exhibit (b) of Form N-2 filed with the Securities Exchange Commission on April 22, 1997. |
| (4) | Specimen certificate of common stock certificate, incorporated by reference to Exhibit (b) of Form N-2 filed with the Securities Exchange Commission on April 22, 1997. |
| (10.1) | Employee Stock Option Plan incorporated by reference Appendix B to the Corporations definitive Proxy Statement filed on June 1, 2002.* | |
| (10.2) | Certificate of Incorporation of Rand Merger Corporation as filed by the NY Department of State on 12/18/08 incorporated by reference to Exhibit 1(a) to Registration Statement No. 811-22276 on Form N-5 of Rand Capital SBIC, Inc. filed with the SEC on 2/6/09. | |
| (10.3) | By-laws of Rand Capital SBIC, Inc. incorporated by reference to Exhibit 2 to Registration Statement No. 811-22276 on Form N-5 of Rand Capital SBIC, Inc. filed with the SEC on 2/6/09. | |
| (10.4) | Certificate of Merger of Rand Capital SBIC, L.P. and Rand Capital Management, LLC into Rand Merger Corporation, as filed by the NY Department of State on 12/18/08 incorporated by reference to Exhibit 1(b) to Registration Statement No. 811-22276 on Form N-5 of Rand Capital SBIC, Inc. filed with the SEC on 2/6/09. | |
| (10.5) | Rand Capital Corporation Amended and Restated Profit Sharing Plan applicable to Rand Capital SBIC, Inc. incorporated by reference to Exhibit 7 to Registration Statement No. 811-22276 on Form N-5 of Rand Capital SBIC, Inc. filed with the SEC on 2/6/09.* | |
| (31.1) | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended-filed herewith | |
| (31.2) | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended filed herewith | |
| (32.1) | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Rand Capital Corporation furnished herewith | |
| (32.2) | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Rand Capital SBIC, Inc. furnished herewith |
| * | Management contract or compensatory plan. |
51
| By: |
/s/
Allen
F. Grum
|
|
Signature
|
Title
|
|||||
| (i) Principal Executive Officer: | ||||||
|
/s/
Allen
F. Grum
|
President | March 14, 2011 | ||||
| (ii) Principal Accounting & Financial Officer: | ||||||
|
/s/
Daniel
P. Penberthy
|
Treasurer | March 14, 2011 | ||||
| (iii) Directors: | ||||||
|
/s/
Allen
F. Grum
|
Director | March 14, 2011 | ||||
|
/s/
Erland
E. Kailbourne
|
Director | March 14, 2011 | ||||
|
/s/
Ross
B. Kenzie
|
Director | March 14, 2011 | ||||
|
/s/
Reginald
B. Newman II
|
Director | March 14, 2011 | ||||
|
/s/
Jayne
K. Rand
|
Director | March 14, 2011 | ||||
|
/s/
Robert
M. Zak
|
Director | March 14, 2011 | ||||
52
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|